{"disease":{"id":"thromboembolic-events","name":"thromboembolic events"},"drugs":{"marketed":[{"drug_id":"chembl-chembl48361","indication_name":"Venous thromboembolic events","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dabigatran Etexilate","generic_name":"DABIGATRAN","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":65,"revenue":"1200","mechanism":"Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process."},{"drug_id":"chembl-chembl48361","indication_name":"Venous thromboembolic events","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dabigatran Etexilate","generic_name":"DABIGATRAN","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":65,"revenue":"1200","mechanism":"Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04523220","title":"Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":704,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05471830","title":"An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06238115","title":"Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04412304","title":"Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06177704","title":"Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","has_results":false},{"nct_id":"NCT04510987","title":"Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy (\"Dialysis\")","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04115436","title":"Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Texas Cardiac Arrhythmia Research Foundation","has_results":false},{"nct_id":"NCT06562985","title":"A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05419635","title":"A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06619483","title":"A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Bayer","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}